A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
NCT05100199
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
328
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Lines
Interventions
DRUG:
OnabotulinumtoxinA X
DRUG:
Placebo
Sponsor
Allergan